Certificate under Regulation 74(5) of the SEBI ( Depositories & Participants) Regulations, 2018
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fredun Pharmaceuticals has submitted a routine quarterly certificate from its Registrar and Share Transfer Agent (RTA), Purva Sharegistry (India) Pvt. Ltd., for the quarter ended September 30, 2025. The certificate confirms that share certificates received from depository participants for dematerialisation during the quarter were duly processed, and the underlying shares are listed on the stock exchanges. As per the attached details, a total of 1,700 shares across 17 certificates (of 100 shares each) were dematerialised between July and September 2025 by three shareholders — Girija Shankar Pandey (1,000 shares), Santosh Deodhar (500 shares), and Parul Trivedi (200 shares). The original physical certificates have been mutilated and cancelled, with the depository's name substituted in the register of members within prescribed timelines.
This is a standard regulatory compliance disclosure with no material impact on the company's financials, operations, or share price. It simply confirms routine processing of share dematerialisation requests.